Analysts predict 10x Genomics will reach cashflow breakeven ...
Analysts predict 10x Genomics will reach cashflow breakeven before depleting its cash reserves. The company appears well-positioned to fund its growth, with options to raise more capital through share issuance or debt.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more